Background. In older individuals, acute medical illnesses and admission to hospital are often associated with a deterioration of cognitive status, also in the absence of dementia and full-blown delirium. We evaluated the prevalence of subsyndromal delirium (SSD) and its correlates in a sample of elderly medical inpatients.
I
N elderly individuals, the onset of acute medical illness is often associated with a decline of cognitive performance (1) (2) (3) (4) ; it has been reported that the prevalence of cognitive impairment might range between 19% and 40% (1) (2) (3) . This phenomenon has been regarded as a marker of poor prognosis because it has been associated with longer stay in hospital, greater probability to be discharged to nursing home, higher disability, and mortality (1) (2) (3) 5) . Even though acute medical events have been related to increased serum anticholinergic activity (6) , the possible causes of cognitive decline associated with acute illness have not been systematically investigated. Fields and coworkers (1) reported that, among medical inpatients, cognitive impairment was associated with severity of illness, clinical instability, and comorbidity. Inouye and coworkers (3) demonstrated the potential reversibility of this phenomenon in older inpatients. These authors identified three independent predictors, namely educational levels, preadmission functional status, and illness severity (3) . More recently, Iwashyna and coworkers (7) found that among older patients sepsis was associated with new persistent cognitive impairment and functional decline. Although delirium and dementia have not been systematically excluded in most previous studies (1) (2) (3) , in the study by Inouye, their prevalence in older inpatients with cognitive impairment was only 20% and 13%, respectively (3), suggesting the existence of a clinical entity conceptually different from delirium and dementia.
A significant portion of medical inpatients with cognitive impairment might be affected by "subsyndromal" delirium (SSD), a frequent condition characterized by the presence of some symptoms of delirium, but not evolving to the full syndrome (8, 9) . At present, there are no officially recognized diagnostic criteria for SSD, and two recent studies (10, 11) gave different definitions of SSD. Nevertheless, it has been shown that SSD is quite common among older patients and might have negative prognostic significance (9, 11, 12) .
In order to prevent SSD, it would be important to understand its pathophysiology, and to identify which factors might contribute to its appearance. The aim of thisstudy was to evaluate the following in a large sample of older patients hospitalized for acute medical illness: (i) the prevalence of SSD, (ii) the clinical characteristics of patients developing SSD, and (iii) the parameters associated with cognitive performance in SSD patients.
Methods

Patients and Measurements
This study was conducted (years 2009-2010) on elderly patients (>64 years) with acute medical illness, consecutively admitted to Acute University Ward of Internal Medicine (Ferrara, Italy) or Geriatrics (Perugia, Italy). On the whole, 763 patients were evaluated. Because the objective was to search for parameters associated with SSD during acute medical illness, dementia and delirium were exclusion criteria. Consequently, 196 demented patients and 129 with full-blown delirium were excluded (n = 325), and 438 patients were enrolled. Excluded patients were older individuals and more frequently female participants.
The cognitive status was evaluated by the Italian version of the Mini Mental Status Examination (MMSE) (13) ; this test was administered to all patients by trained physicians within 48 hours from admission to hospital.
Dementia diagnosis was based on the following Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV) criteria, using multiple sources of information: detailed anamnesis, functional status in basic activities of daily living (BADLs) and instrumental activities of daily living (IADLs), charts and drugs review, patients interview, relatives interview, and clinical examination.
Delirium diagnosis was based on the following DSM-IV criteria: (i) disturbance of consciousness; (ii) change in cognition or development of perceptual disturbance not accounted for by preexisting dementia; (iii) development of disturbance over a short period of time, and its fluctuation; (iv) evidence that disturbance was caused by a general medical condition.
The diagnosis of SSD was made, within 48 hours from admission to hospital, in the presence of at least two of the DSM-IV criteria for delirium. The core symptoms were (i) disorientation, (ii) attention deficit, (iii) memory deficit, and (iv) altered level of consciousness. MMSE items were utilized to evaluate deficit of attention (countdown), disorientation (time orientation), and memory deficit (three items delayed recall). The presence of disturbance of consciousness, categorized as dichotomous (Yes or No), was assessed by continuous clinical observation, and daily reviewed together by physicians and nurses; no standardized tool was used. No cases of perceptual disturbances were reported, as probably associated with fullblown delirium or dementia, and thus previously excluded.
The following parameters were evaluated and included on database:
• General parameters: age, gender, years of formal education, and widowhood status.
• Clinical parameters: heart rate (beats per minute), systolic blood pressure and diastolic blood pressure, arterial oxygen saturation (SO 2 ), body mass index (kg/m 2 ), comorbidity (number of chronic medical conditions), length of hospitalization, number of drugs taken during hospitalization, BADLs, and IADLs before admission (14, 15) . The principal discharge diagnosis and the three most important secondary diagnoses were also obtained from discharge records. For heart rate, systolic blood pressure, diastolic blood pressure, and SO 2 mean values were calculated from three different measurements obtained during the first 3 days of hospitalization (overlapping the days when MMSE was administered).
• Clinical chemistry parameters: On the morning after admission, hemoglobin, total cholesterol, triglycerides, high-density lipoprotein cholesterol, blood glucose, serum albumin, creatinine, iron, fibrinogen, white blood cells count, and lymphocytes were measured on serum/ plasma by standardized methods in blood samples from fasting patients. High-sensitivity C reactive protein (hs.CRP) was measured by using the CRP.HS Cobas immunoturbidimetric test (Roche diagnostics GmbH Mannheim, Germany). Normal range values: 0-0.5 mg/ dL; high levels: more than 3.0 mg/dL.
Diagnosis of diabetes was based on the following: (i) history of diabetes or current hypoglycemic therapy, (ii) fasting glycemia more than or equal to 126 mg/dL in two or more measurements, and (iii) glycemia more than or equal to 200 mg/dL 120 min after oral glucose load. Diagnosis of hypertension was based on the following: (i) history of hypertension or antihypertensive therapy, and (ii) blood pressure more than or equal to 140/90 mmHg in three or more measurements. Diagnosis of coronary heart disease was made in the presence of a documented history of previous myocardial infarction or angina.
The study protocol was approved by the Ethical Committee of the University Hospital S. Anna of Ferrara. The study was conducted in accordance with the Helsinki Declaration as revised in 1989.
Statistical Analysis
Continuous variables were expressed as mean (± standard deviation) or median (interquartile range) when their distribution was not normal. Prevalence was compared using the chisquare test. Means were compared using analysis of variance. Medians were compared using the MannWhitney test. Bivariate correlations were analyzed using Spearman's test. Multivariate linear regression analysis was used to test the independent association between MMSE and other variables of interest. Only parameters associated with MMSE at univariate analysis or variables know to be associated with MMSE entered regression analysis. Variables not-normally distributed (hs.CRP, SO 2 , comorbidity, and creatinine) were log-transformed before entering regression analysis.
SPSS for Windows, version 13.0 (SPSS, Chicago, IL) statistical packages were used.
Results
Among 438 patients enrolled, 166 resulted affected by SSD by the adopted criteria (37%). Among the 129 patients excluded from the study because they are affected by delirium, 46 (36%) had received a diagnosis of SSD, whereas 83 (64%) did not. Thus, the rate of delirium onset was about 30% both in SSD and in control patients.
The most frequent diseases were congestive heart failure (18.8%), coronary heart disease (17.1%), gastroenteric diseases (15.2%), diabetes (12.2%), chronic obstructive pulmonary disease (11.4%), cancer (9.8%), urinary tract infection (8.7%), and pneumonia (8%).
The principal characteristics of the sample, according to the absence or presence of SSD, are described in Table 1 .
The mean age was 80.6 years, female participants represented 60.1%. As expected, the median value for years of formal education was low (5 years).
The median MMSE score was lower in SSD patients (20/30) compared with controls (27/30). Interestingly, in SSD patients, the three MMSE items used for SSD diagnosis (attention, time orientation, and delayed memory) explained about 55% of MMSE total variability (adjusted r 2 = 0.56). We calculated that a MMSE score cutoff of 24/30 better identified the presence of SSD, with a sensitivity of 88% and a specificity of 78%. This means that although SSD does not coincide with lower MMSE, finding a MMSE less than 24/30 might help clinicians in identifying participants with high probability of having SSD; that is, 12% of SSD cases will be lost, whereas 22% of participants with MMSE less than 24/30 will not have SSD.
Compared with controls, SSD patients were older individuals, had less years of education, higher comorbidity, lower hemoglobin and lymphocytes count, and higher creatinine levels. SSD was neither associated with the presence of diabetes, hypertension, depression nor with current treatment with antibiotics, corticosteroids, or benzodiazepines. A trend toward an increase in the length of stay in hospital and in prevalence of previous stroke (15% vs 10%) and widowhood (53% vs 46%) was observed in SSD compared with controls. In Table 2 , the correlations between MMSE and other parameters according to the presence or absence of SSD are reported. In the whole sample, MMSE was inversely correlated with age, comorbidity (ie, the number of medical conditions), hs.CRP, and creatinine levels. A positive correlation was observed with years of education, Barthel index before admission, hemoglobin levels, SO 2 , lymphocytes count, and diastolic blood pressure. Of interest, in controls, most of these correlations were lost with the exception of formal education, whereas in SSD patients several variables correlated with MMSE, including years of education, Barthel index, serum albumin, hs.CRP, and SO 2 .
By multivariate analysis, we searched for variables independently associated with MMSE (Table 3 ). In the whole sample (Model 1), MMSE correlated with years of education, age, and hs.CRP levels (adjusted r 2 = 0.21, p = .001) independent of possible confounders. However, because variables associated with MMSE at univariate analysis were sensibly different depending on the absence or presence of SSD, two separate models were tested. In controls (Model 2), only years of education were associated with MMSE (adjusted r 2 = 0.06, p = .01). On the contrary, in SSD patients (Model 3), MMSE correlated with years of education, SO 2 , and hs.CRP levels (adjusted r 2 = 0.30, p = .001).
Discussion
It has been suggested that, in the elderly individuals, the onset of acute medical illness is often associated with a significant and potentially reversible impairment of brain functioning (1-4). We evaluated SSD prevalence in a sample of older individuals hospitalized for acute medical illness, and searched for variables associated with SSD and cognitive performance in SSD patients. After excluding individuals with dementia or delirium, 37% of patients had SSD using our criteria. These results are in good agreement with previous reports. In an intensive care unit, Ouimet and coworkers (8) found a SSD prevalence more than 33%. Kieley and coworkers found that, at admission to postacute facility, nearly 50% of older participants had one or more symptoms of delirium (9) . Among long-term care demented residents, Voyer and coworkers (10) found a SSD prevalence of about 50%. Thus, it appears that, depending on the medical setting, 30%-50% of elderly patients might display symptoms of SSD.
Successively, we tried to characterize the inpatients receiving a diagnosis of SSD. They were older individuals, more frequently widows, had higher comorbidity, and less years of education; their lymphocytes/hemoglobin counts were also lower. Moreover, a trend toward a higher prevalence of functional dependence and previous stroke emerged. On the whole, these data suggest that SSD patients might be "more frail" compared with controls. The loss of cognitive reserve has been included among frailty criteria (16) , and it has been shown that frailty is associated with mild cognitive impairment (17) . Less years of formal education, older age, widowhood status, and worst nutritional state, might contribute in reducing brain homeostatic capabilities in SSD patients; unlike controls, these individuals would be unable to cope with acute stress caused by acute illness and hospitalization.
Finally, we searched for parameters associated with cognitive performance in this specific population. We hypothesized that in SSD patients, the determinants of cognitive performance might be different from controls. In the whole sample, years of education, age, and hs.CRP levels explained about 20% of MMSE variability. Nevertheless, we found that in controls, MMSE was associated only with years of education (explaining 6% of variability), whereas in SSD patients, years of formal education, hs.CRP, and SO 2 , explained 30% of MMSE variability.
It is known that cognitive performance varies by age and education (18) . A better performance on cognitive tests among participants with higher education has been observed (19) (20) (21) , and it might represent better test-taking skills, a deeper fund of knowledge, or similar mechanisms (22) . Higher education may confer a greater cognitive reserve, possibly due to higher cortical synaptic density or a fuller repertoire of acquired skills for coping with the progressive mental impairment associated with aging (22). A much more interesting finding was the negative relationship between cognitive status and hs.CRP levels in SSD patients. Previous studies suggest the existence of a correlation between chronic low-grade systemic inflammation and cognitive decline (23) (24) (25) , dementia (26-28) and disability, both in demented (29) and community dwelling older individuals (30) . CRP levels are modulated by interleukin 6 (31), and increased interleukin 6 has been also associated with dementia and cognitive decline (32) (33) (34) . Of interest, peripheral markers of inflammation partially reflect the condition inside the central nervous system, as cytokines cross the blood-brain barrier (35) . The negative association between cognitive performance and hs.CRP during acute medical illness suggests a detrimental effect of acute phase reaction on cognitive performance. Nevertheless, it has to be underlined that this relationship was present exclusively in SSD patients. This phenomenon could not be explained by different levels of systemic inflammation in the two groups because, paradoxically, a trend toward lower levels of hs.CRP in SSD patients was observed. Instead, it might depend on the different level of vulnerability of the two groups. We advance that the detrimental effect of systemic inflammation would affect only SSD patients because they might represent those with reduced cognitive reserve. The relationship between hs.CRP and cognitive performance might be "causal" in the case CRP would be able to influence cognitive performance. Animal experiments suggest that the administration of CRP into lateral ventricles determines a decline in memory (36) . Alternatively, the relationship between CRP and cognitive performance might be "non-causal," CRP representing just a marker of ongoing acute phase reaction. In healthy volunteers, the intravenous administration of bacterial toxins is associated with significant memory decline (37, 38) . Moreover, although high levels of tumor necrosis factor-α are associated with cognitive impairment (39), the spinal administration of Etanercept in patients with Alzheimer's disease was followed by rapid improvement of language and memory (40) . Thus, current literature suggests that chronic or acute inflammation might negatively influence the cognitive performance of previously "healthy" participants, and this is in good agreement with our results.
Similar comments should be done for the relationship between cognitive performance and SO 2 . Again, SO 2 was independently associated with MMSE only in SSD patients, also after adjustment for congestive heart failure or chronic obstructive pulmonary disease, two conditions associated with reduced SO 2 . Thus, it appears that systemic inflammation and mild grade of hypoxia might contribute to cognitive impairment in older inpatients, but only in those with SSD, which might represents those with reduced cognitive reserve. Alternatively, CRP and SO 2 might be markers of a more severe clinical condition associated with SSD. Nevertheless, although we did not include a validated index of diseases severity, we adjusted our analysis for several parameters related to clinical condition (congestive heart failure, urinary tract infection, comorbidity, functional status, hemoglobin, and lymphocytes count).
Finally, we have to acknowledge the limitations of this study. First, due to the cross-sectional design, a causal association between hs.CRP and cognitive performance cannot be established; we cannot rule out the hypothesis that unmeasured factors might directly influence both hs.CRP levels and cognitive performance in SSD patients. Second, because MMSE was administered within 48 hours from admission, we do not have information about the modification of cognitive status over time; although we accurately verified the absence of full-blown delirium, we ignore whether cognitive functions improved or worsened by the time of discharge, and this might be important for Notes. Model 1: age, gender, years of formal education, comorbidity, hs.CRP, creatinine, hemoglobin, arterial oxygen saturation, lymphocytes count, diastolic blood pressure, previous stroke, widowhood status, congestive heart failure, and urinary tract infection; Model 2: age, gender, years of formal education, comorbidity, widowhood status, previous stroke, depression, diabetes, and hypertension; Model 3: age, gender, years of formal education, comorbidity, hs.CRP levels, arterial oxygen saturation, previous stroke, depression, diabetes, hypertension, congestive heart failure, and urinary tract infections. Hs.CRP = high-sensitivity C reactive protein.
Downloaded from https://academic.oup.com/biomedgerontology/article-abstract/68/10/1296/568397 by guest on 07 April 2019 long-term outcomes (41) . Third, we cannot exclude that some demented individuals were present in our sample, perhaps included into SSD group. As regards this argument, we recently found a dementia prevalence less than 10% in a large sample of inpatients from Ferrara University Hospital (42) ; consequently, the number of demented individuals should not exceed 20 in our sample, and this would not invalidate our results.
In conclusion, we found that among elderly patients hospitalized for acute medical illness, SSD was diagnosed in 37% of participants. Patients with SSD appear to have a worst clinical condition compared with controls, suggesting the presence of a reduced cognitive reserve. Besides formal education, current inflammatory response and reduced SO 2 were the two only independent determinants of cognitive performance in older inpatients with diagnosis of SSD.
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